SCIENTIFIC UPDATE - Key Persons
Andrew Teasdale PhD has 30 years' experience in the pharmaceutical industry as an analytical chemist and within quality assurance and regulatory roles. In his current role he chairs AstraZeneca's Impurity Advisory Group. Dr Teasdale has published a number of papers relating to mutagenic impurities, N Nitrosamines, extractables and leachables, and other impurity related matters. He is currently the chair of the Extractables and Leachables safety Information exchange (ELSIE) and also led a number of industry expert groups; these include both safety and quality groups within Pharmaceutical Research and Manufacturers of America (PhRMA), European Federation of Pharmaceutical Industries and Associations (EFPIA), Product Quality Research Institute (PQRI) . Andrew has also represented EFPIA in ICH Q3C, Q3D and Q3E Expert working groups. He has also advanced a number of key scientific advancements in the control of impurities as the inventor of the purge factor concept and the instigator of the development of Elemental Impurities database for excipients.
With over 50 scientific papers, he has also written 3 books:
Genotoxic Impurities - Strategies for Identification and control. Editor A Teasdale. Publisher Wiley. ISBN 978-0-470-49919-1
ICH Quality Guidelines - An Implementation Guide. Editors A Teasdale, D Elder, R W Nims. Publisher Wiley. ISBN 978-1-118-97111-6.
Mutagenic Impurities - Strategies for Identification and Control Second Edition. Editor A Teasdale. Publisher Wiley. ISBN 978-1-119-55121-8
Job Titles:
- Technical Associate, North America & Asia Pacific
Ben Littler joins Scientific Update as Technical Associate North America and Asia Pacific
Claire's responsibilities include: Marketing, Business Development and Conference Management
Felix Roessler (F.R.) studied chemistry at the University of Zürich (UZH), Switzerland. After obtaining his PhD at UZH, he moved to Cambridge (GB) to work on organosilicon chemistry with Ian Fleming. He started his industrial career with Roche in Basel in 1980, first with central research where his focus was heterogeneous catalysis for the production of pharmaceuticals and fine chemicals and where he invented and developed an in-house high throughput screening system, particularly for investigating chemical reactions under elevated pressure/temperature conditions on a small scale, 10 years ahead of the emergence of commercially available systems. Next step was process research and development within the Roche's pharma division, supporting medicinal chemistry, development and production regarding heterogeneous catalytic reactions. In 2000 F.R. joined the vitamins division of Roche, where he initiated, developed and introduced highly economic and ecologic heterogeneous catalytic processes for the production of nutraceuticals. Along with the takeover of Roche vitamins by DSM in 2004, F.R. worked as catalysis expert for DSM where he supported catalysis for the nutraceutical, pharma and base chemical divisions.
F.R. was honoured twice with the Sandmeyer award in 1997 and 2008, granted by the Swiss Chemical Society. He is author of 18 publications, co-author of monographs and holds 4 patents.
John Studley joins Scientific Update as Scientific Director
Dr Stephen Rowe graduated from Portsmouth University with a BSc First Class Honours Degree in Applied Chemistry in 1991 having undertaken a project developing the adiabatic Dewar calorimeter system in 1989 - 1990 within the ICI Hazards and Process Studies Group in Manchester. He joined Chilworth Technology in 1991 and successfully completed his PhD in 1997 under the guidance of Prof. Philip Nolan at South Bank University (University of London). The project investigated the application of reaction inhibition techniques in the control of exothermic runaway reactions. Stephen is currently the Managing Director at Chilworth Technology Ltd - a recently acquisition of the DEKRA SE company. His technical expertise is primarily in the areas of Chemical Reaction Hazards and Flammability (dusts, vapours and gases). Stephen has full responsibility for the management and technical development of the testing and consulting operations at DEKRA's UK headquarters in Southampton.
Vittorio Farina studied organic chemistry at the University of Pisa, where he received his BS/MS degree. He studied further at the University of Alberta in Edmonton (Canada), where he received a PhD under Prof. Derrick L. J. Clive. After a postdoctoral stay at Cornell University with Prof. John McMurry, in 1983 he accepted a position in the Chemical Development department at Bristol-Myers in Syracuse (New York, USA). In 1987, he moved to the anticancer research department of Bristol-Myers in Wallingford, Connecticut.
In 1993, he left Bristol-Myers Squibb, joined Boehringer Ingelheim in Ridgefield, Connecticut, where he led the process development department for over a decade. In 2006, he moved back to Europe, accepting a position of Senior Director in the Chemical Development group of Janssen Pharmaceutica in Beerse, Belgium. In 2019, after over three decades of activities developing chemical processes toward Active Pharmaceutical Ingredients, he founded Farinachem Consulting GmbH. The consulting company is based in the Frankfurt area (Germany).
Dr. Farina has authored ca. 120 peer-reviewed publications, several books and book chapters and is the inventor of over 20 patents. He is on the advisory board of Advanced Synthesis and Catalysis and Organic Reactions, as well as on the board of the Ischia Advanced School of Organic Chemistry and the International Symposium of Homogeneous Catalysis. He has also chaired several conferences and symposia, i.a., the 2012 Gordon Research Conference on Stereochemistry in Newport, Rhode Island.
Among his other activities, he is a co-founder of ISPROCHEM, an international school of process development being held yearly on the banks of Lake Garda in Gargnano, Italy. Dr. Farina's activities involve consulting on process development issues and teaching.
Hannah's responsibilities include: Planning the conference and course programmes each year, all event logistics and generally making sure everyone is HAPPY - Director of Happiness
Responsibilities: Social Media Marketing, Marketing and Business Development support to Director Claire Francis
Phoebe's responsibilities include: Event planning and management, Book sales & Adding a creative flair
Vicky's responsibilities include: Conference planning, organising the in house training courses, looking after our direct mail campaigns and keeping data up to date.